TY - JOUR A1 - Baum, Petra A1 - Toyka, Klaus V. A1 - Blüher, Matthias A1 - Kosacka, Joanna A1 - Nowicki, Marcin T1 - Inflammatory mechanisms in the pathophysiology of diabetic peripheral neuropathy (DN) — new aspects JF - International Journal of Molecular Sciences N2 - The pathogenesis of diabetic neuropathy is complex, and various pathogenic pathways have been proposed. A better understanding of the pathophysiology is warranted for developing novel therapeutic strategies. Here, we summarize recent evidence from experiments using animal models of type 1 and type 2 diabetes showing that low-grade intraneural inflammation is a facet of diabetic neuropathy. Our experimental data suggest that these mild inflammatory processes are a likely common terminal pathway in diabetic neuropathy associated with the degeneration of intraepidermal nerve fibers. In contrast to earlier reports claiming toxic effects of high-iron content, we found the opposite, i.e., nutritional iron deficiency caused low-grade inflammation and fiber degeneration while in normal or high non-heme iron nutrition no or only extremely mild inflammatory signs were identified in nerve tissue. Obesity and dyslipidemia also appear to trigger mild inflammation of peripheral nerves, associated with neuropathy even in the absence of overt diabetes mellitus. Our finding may be the experimental analog of recent observations identifying systemic proinflammatory activity in human sensorimotor diabetic neuropathy. In a rat model of type 1 diabetes, a mild neuropathy with inflammatory components could be induced by insulin treatment causing an abrupt reduction in HbA1c. This is in line with observations in patients with severe diabetes developing a small fiber neuropathy upon treatment-induced rapid HbA1c reduction. If the inflammatory pathogenesis could be further substantiated by data from human tissues and intervention studies, anti-inflammatory compounds with different modes of action may become candidates for the treatment or prevention of diabetic neuropathy. KW - diabetic neuropathy KW - pathogenesis KW - inflammation KW - iron KW - treatment-induced neuropathy in diabetes (TIND) Y1 - 2021 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-284556 SN - 1422-0067 VL - 22 IS - 19 ER - TY - JOUR A1 - Hausoel, A. A1 - Karolak, M. A1 - Şaşιoğlu, E. A1 - Lichtenstein, A. A1 - Held, K. A1 - Katanin, A. A1 - Toschi, A. A1 - Sangiovanni, G. T1 - Local magnetic moments in iron and nickel at ambient and Earth's core conditions JF - Nature Communications N2 - Some Bravais lattices have a particular geometry that can slow down the motion of Bloch electrons by pre-localization due to the band-structure properties. Another known source of electronic localization in solids is the Coulomb repulsion in partially filled d or f orbitals, which leads to the formation of local magnetic moments. The combination of these two effects is usually considered of little relevance to strongly correlated materials. Here we show that it represents, instead, the underlying physical mechanism in two of the most important ferromagnets: nickel and iron. In nickel, the van Hove singularity has an unexpected impact on the magnetism. As a result, the electron–electron scattering rate is linear in temperature, in violation of the conventional Landau theory of metals. This is true even at Earth’s core pressures, at which iron is instead a good Fermi liquid. The importance of nickel in models of geomagnetism may have therefore to be reconsidered. KW - ferromagnetism KW - electronic properties and materials KW - magnetic properties and materials KW - nickel KW - iron Y1 - 2017 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-170681 VL - 8 IS - 16062 ER - TY - JOUR A1 - Macdougall, Iain C. A1 - Bircher, Andreas J. A1 - Eckhardt, Kai-Uwe A1 - Obrador, Gregorio T. A1 - Pollock, Carol A. A1 - Stenvinkel, Peter A1 - Swinkels, Dorine W. A1 - Wanner, Christoph A1 - Weiss, Günter A1 - Chertow, Glenn M. T1 - Iron management in chronic kidney disease: conclusions from a "Kidney Disease: Improving Global Outcomes" (KDIGO) Controversies Conference JF - Kidney International N2 - Before the introduction of erythropoiesis-stimulating agents (ESAs) in 1989, repeated transfusions given to patients with end-stage renal disease caused iron overload, and the need for supplemental iron was rare. However, with the widespread introduction of ESAs, it was recognized that supplemental iron was necessary to optimize hemoglobin response and allow reduction of the ESA dose for economic reasons and recent concerns about ESA safety. Iron supplementation was also found to be more efficacious via intravenous compared to oral administration, and the use of intravenous iron has escalated in recent years. The safety of various iron compounds has been of theoretical concern due to their potential to induce iron overload, oxidative stress, hypersensitivity reactions, and a permissive environment for infectious processes. Therefore, an expert group was convened to assess the benefits and risks of parenteral iron, and to provide strategies for its optimal use while mitigating the risk for acute reactions and other adverse effects. KW - chronic kidney disease KW - hypersensitivity KW - infections KW - iron KW - overload KW - oxidative stress Y1 - 2016 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-191467 VL - 89 IS - 1 ER - TY - THES A1 - Mäurer, André Germar Paul T1 - Analysis of the Chlamydophila pneumoniae and host transcriptome in the acute and iron depletion-mediated persistent infection T1 - Analyse des Transkriptoms von Chlamydophila pneumoniae und der Wirtszelle während der akuten und der durch Eisenmangel vermittelten persistenten Infektion N2 - The obligate intracellular gram-negative bacterium, Chlamydophila pneumoniae (Cpn), has a significant impact as an acute and chronic disease-causing pathogen. Its potential to undergo persistent infections has been linked to chronic diseases. Several in vitro cell culture models are used to study persistent conditions, mainly IFN_ stimulation, treatment with antibiotics and iron depletion. Little is known about changes in the Cpn transcriptome during the acute and persistent infection. Therefore, the Cpn transcriptome during its acute developmental cycle and iron depletion-mediated persistence was examined in this study. Based on expression profiles, genes with similar expression changes formed 12 clusters using the self-organizing map algorithm. While other studies define genes based on their onset of transcription, here the important feature for clustering was the expression profile. This turned out to be more appropriate for comparing the time specific relevance of a certain cluster of genes to their proposed functions in the cycle. The Cpn clusters were grouped into the 'Early', 'Mid' and 'Late' classes as described for Ctr. Additionally, a new gene expression class containing genes with steadily increasing expression at the end of the developmental cycle was defined and termed 'Tardy' class. Comparison of the Cpn clusters to published proteomics data showed that genes encoding elementary body (EB) proteins peaked in the 'Late' gene cluster. This indicated that genes of the ‘Late’ and ‘Tardy’ class have different roles in RB to EB re-differentiation. Moreover, using lexical comparison the EB mRNA profile was significantly linked to the ‘Tardy’ cluster class. This provided evidence that initial translation in the cycle might be directed from stable transcripts present in the infectious EB form. Based on these criteria the novel ‘Tardy’ class was separated from the ‘Late’ class. The gene ontologies were used to identify specific pathways and physiological functions active during the different phases of development. Additionally, the transcriptome of Cpn in the persistent stage was compared to that of the acute developmental cycle. The Cpn transcriptome was altered in the iron-depletion mediated persistence. Genes upregulated were linked to clusters at the beginning of the developmental cycle, and genes down-regulated were linked to clusters at the end of the developmental cycle. These data provided strong evidence that the Cpn transcriptome during persistence is a gene expression arrest in mid-development. In early acute infection convergently or divergently oriented gene pairs preferentially had an antagonistic expression profile, whereas tandemly oriented gene pairs showed a correlated expression profile. This suggests that the Cpn genome is organized mainly in tandemly arranged operons and in convergently or divergently oriented genes with favored antagonistic profiles. The microarray studies done with the Cpn strain CWL029 also showed expression signals for several genes annotated only for the Cpn strains AR39 and J138. BLAST comparison verified that these genes are also coded in the CWL029 genome. Several of these genes were convergently arranged with their neighboring gene and shared overlapping genome information. Among these were parB, involved in DNA segregation and rpsD, an alternative sigma factor responsible for the transcription at late stages of the developmental cycle. Both genes have been described to have major roles in the chlamydial cycle. These genes had an antagonistic expression profile at the beginning of the acute developmental cycle and in persistence, as described before to be predominant for convergently oriented genes. Real time RT-PCR analysis showed that full-length rpsD mRNA transcripts were down-regulated, whereas short-length rpsD mRNA transcripts were up-regulated during the persistent infection. This demonstrated that the rpsD promoter is activated during the persistent infection and that because of the collision of the RNA polymerases full length transcripts were down-regulated. This sigma factor-independent mechanism is known as ‘Transcriptional Interference’. This is the first description on how the alternative sigma factor rpsD might be down-regulated during persistent infections. Finally, the host cell transcriptome was analyzed in the acute and persistent infection mediated by the depletion of iron. Cpn infection triggered the upregulation of relB, involved in an alternative NF-KB signaling pathway. Several genes coding for cell cycle proteins were triggered, including cyclin G2 and cyclin D1 and inhibitors of CDK4. Taken together, this work provides insights into the modulation of the pathogen and the host transcriptome during the acute infection and the iron mediated persistent infection. N2 - Das obligat intrazelluläre, gram-negative Bakterium Chlamydophila pneumoniae (Cpn) wird mit akuten und chronischen Krankheiten in Verbindung gebracht. Besonders sein Potential persistente Infektionen zu durchlaufen ist mit chronischen Krankheiten korreliert worden und deshalb von besonderem Interesse. Verschiedene in vitro Zellkulturmodelle werden verwendet um persistente Infektionen zu untersuchen, darunter IFN_ Stimulation, Antibiotika Behandlung und Eisenmangel. Über die Genregulation von Cpn als auch der Wirtzelle in der akuten und persistenten Infektion ist jedoch wenig bekannt. In dieser Arbeit wurde das Cpn Transkriptom als auch das von epithelialen Wirtszellen in der akuten und in der durch Eisenmangel induzierten Infektion untersucht. Mittels eines Algorithmuses für ‚selbstorganisierende Netzwerke’ (SOM) wurden signifikant regulierte Gene aufgrund ihres Expressionsprofiles in 12 Cluster gegliedert. Diese 12 Cluster wurden wiederum in die Klassen der ‘Frühen’ (engl.: ‘Early’), ‘Mittleren’ (engl.: ‘Mid’) und ‘Späten’ (engl.: ‘Late’) Gene eingeteilt. Diese Unterteilung lehnt sich an schon beschriebenen Genexpressionsstudien für Ctr an. Weiterhin wurde die neue Klasse der ‘Verspäteten’ (engl.: ‘Tardy’) Gene eingeführt. Diese hatten am Ende des Entwicklungszykluses ein kontinuierlich ansteigendes Expressionsprofil. Mit publizierten Proteinen aus chlamydialen Elementarkörperchen (EK) korrelierten vor allem Gene aus den ‘Späte’ jedoch nicht aus den ‘Verspätete’ Klassen. Gene dieser beiden Klassen müssen also eine unterschiedliche Rolle im EK Redifferenzierungsprozess spielen. Weiterhin waren überdurchschnittlich viele mRNA Transkripte aus der Klasse der ‘Verspäteten’ Gene in den EK vorhanden. Dies führte zu der Annahme, daß ein Teil der initiale Proteinexpression von stabilen mRNA-Transkripten aus der infektiösen EK Form erfolgt. Anschließend wurden, Gene, die für spezifische Signalwege und physiologische Funktionen von Cpn kodieren, basierend auf der ‚Gene Ontology’ während des Entwicklungszykluses untersucht. Weiterhin wurde das Transkriptom von Cpn in der Persistenz mit dem Transkriptom der akuten Infektion verglichen. Unter Persistenzbedingungen zeigte Cpn ein verändertes Expressionsprofil. Hochregulierte Gene konnten akuten Clustern am Anfang des akuten Entwicklungszykluses und herunterregulierte Gene Clustern am Ende des akuten Entwicklungszykluses zugeordnet werden konnten. Dies legt nahe, daß es sich bei der Persistenz nicht um ein neues Transkriptionsprofil handelt, sondern eher um eine Arretierung des Transkriptomes in der Mitte des akuten Entwicklungszykluses. Weiterhin zeigten konvergent und divergent orientierte Gene am Anfang des Zyklus bevorzugt ein antagonistisches Expressionsprofil, während in Reihe angeordnete (‘tandem’) Gene ein korreliertes Expressionsprofil aufwiesen. Bei den mit dem Cpn Stamm CWL029 durchgeführten Mikroarrayexperimenten konnten auch Expressionswerte für einige ausschließlich für die Stämme AR39 und J138 beschriebenen Gene gemessen werden. Ein Vergleich mittels BLAST zeigte, daß diese Gene auch im CWL029 Genom kodiert sind. Dazu gehörten mehrere Gene, welche konvergent zu ihren Nachbargenen orientiert waren und eine Sequenzüberlappung mit diesen aufwiesen. Darunter fielen parB, welches eine Rolle für die Trennung der DNA in der Zellteilung spielt, und rpsD, ein alternativer Sigma-Faktor, der für die Transkription in der späten Phase des Entwicklungszyklus verantwortlich ist. Für beide Genpaare konnte in der frühen akuten und in der persistenten Infektion ein antagonistisches Expressionsprofil beobachtet werden, wie es bei konvergent orientierten Genpaaren überwiegt. Mittels quantitativer qRT-PCR wurde für rpsD gezeigt, dass vollständige mRNA-Fragmente in der Persistenz herunterreguliert, während kurze mRNA-Fragmente hochreguliert waren. Als Erklärung für diesen Effekt dient ein Modell, welches auf einer Kollision der RNA Polymerasen basiert. Dieser Sigma-Faktor unabhängige Mechanismus ist in der Literatur als ‘Transkriptionelle Interferenz’ bekannt und führt so trotz einer Promoteraktivierung zu einer verminderten Anzahl an vollständigen mRNA Transkripten. Die Herunterregulation von RpsD auf Proteinebene in der Cpn Persistenz ist beschrieben worden. Im letzten Teil dieser Arbeit wurde das Wirtszelltranskriptom in der akuten und persistenten Infektion untersucht.Infektion mit Cpn führte zu einer Hochregulation von relB, welches an alternativen NF-KB Signalwegen beteiligt ist und das anti-apoptotische Potential verstärkt. Weiterhin waren Gene differentiell exprimiert, welche für die Zellzyklusproteine Cyclin-G2 und Cyclin-D1 sowie Inhibitoren von CDK4 kodieren. Zusammenfassend gibt diese Arbeit gibt einen Einblick sowohl in das Transkriptom des Pathogens als auch der Wirtszelle während der akuten und durch Eisenmangel ausgelösten persistenten Infektion als auch potentiellen Mechanismen zu Persistenzentstehung auf der Ebene der Genregulation. KW - Chlamydia pneumoniae KW - Infektion KW - Transkriptom KW - Eisenmangel KW - Transkiptom KW - Eisen KW - Chlamydien KW - Chlamydophila pneumoniae KW - Mikroarray KW - transkiptome KW - iron KW - Chlamydia KW - Chlamydophila pneumoniae KW - microarray Y1 - 2006 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-21415 ER - TY - JOUR A1 - Riederer, Peter A1 - Laux, Gerd T1 - MAO-inhibitors in Parkinson's Disease JF - Experimental Neurobiology N2 - Monoamine oxidase inhibitors (MAO-I) belong to the earliest drugs tried in Parkinson's disease (PD). They have been used with or without levodopa (L-DOPA). Non-selective MAO-I due to their side-effect/adverse reaction profile, like tranylcypromine have limited use in the treatment of depression in PD, while selective, reversible MAO-A inhibitors are recommended due to their easier clinical handling. For the treatment of akinesia and motor fluctuations selective irreversible MAO-B inhibitors selegiline and rasagiline are recommended. They are safe and well tolerated at the recommended daily doses. Their main differences are related to (1) metabolism, (2) interaction with CYP-enzymes and (3) quantitative properties at the molecular biological/genetic level. Rasagiline is more potent in clinical practise and has a hypothesis driven more favourable side effect/adverse reaction profile due to its metabolism to aminoindan. Both selegiline and rasagiline have a neuroprotective and neurorestaurative potential. A head-to head clinical trial would be of utmost interest from both the clinical outcome and a hypothesis-driven point of view. Selegiline is available as tablet and melting tablet for PD and as transdermal selegiline for depression, while rasagiline is marketed as tablet for PD. In general, the clinical use of MAO-I nowadays is underestimated. There should be more efforts to evaluate their clinical potency as antidepressants and antidementive drugs in addition to the final proof of their disease-modifying potential. In line with this are recent innovative developments of MAO-I plus inhibition of acetylcholine esterase for Alzheimer's disease as well as combined MAO-I and iron chelation for PD. KW - selegiline KW - rasagiline KW - moclobemide KW - phenelzine KW - tranylcypromine KW - acetylcholine KW - Alzheimer disease KW - antidepressive agents KW - depression KW - freezing KW - head KW - indans KW - iron KW - levodopa KW - monoamine oxidase KW - monoamine oxidase inhibitors KW - Parkinson disease Y1 - 2011 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-140930 VL - 20 IS - 1 ER - TY - JOUR A1 - Sian-Hulsmann, Jeswinder A1 - Riederer, Peter T1 - The nigral coup in Parkinson's Disease by α-synuclein and its associated rebels JF - Cells N2 - The risk of Parkinson's disease increases with age. However, the etiology of the illness remains obscure. It appears highly likely that the neurodegenerative processes involve an array of elements that influence each other. In addition, genetic, endogenous, or exogenous toxins need to be considered as viable partners to the cellular degeneration. There is compelling evidence that indicate the key involvement of modified α-synuclein (Lewy bodies) at the very core of the pathogenesis of the disease. The accumulation of misfolded α-synuclein may be a consequence of some genetic defect or/and a failure of the protein clearance system. Importantly, α-synuclein pathology appears to be a common denominator for many cellular deleterious events such as oxidative stress, mitochondrial dysfunction, dopamine synaptic dysregulation, iron dyshomeostasis, and neuroinflammation. These factors probably employ a common apoptotic/or autophagic route in the final stages to execute cell death. The misfolded α-synuclein inclusions skillfully trigger or navigate these processes and thus amplify the dopamine neuron fatalities. Although the process of neuroinflammation may represent a secondary event, nevertheless, it executes a fundamental role in neurodegeneration. Some viral infections produce parkinsonism and exhibit similar characteristic neuropathological changes such as a modest brain dopamine deficit and α-synuclein pathology. Thus, viral infections may heighten the risk of developing PD. Alternatively, α-synuclein pathology may induce a dysfunctional immune system. Thus, sporadic Parkinson's disease is caused by multifactorial trigger factors and metabolic disturbances, which need to be considered for the development of potential drugs in the disorder. KW - Parkinson's disease KW - substantia nigra KW - alpha-synuclein KW - genetics KW - iron KW - neuroinflammation KW - viruses KW - immunology KW - aging and cell death Y1 - 2021 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-234073 SN - 2073-4409 VL - 10 IS - 3 ER -